Second cancers and Richter transformation are the leading causes of death in patients with trisomy 12 chronic lymphocytic leukemia

Clinical Lymphoma, Myeloma and Leukemia

Volumn 15, Issue 7, 2015, Pages 420-427

  Strati, Paolo ^a   Abruzzo, Lynne V ^a   Wierda, William G ^a   O'Brien, Susan ^a   Ferrajoli, Alessandra ^a   Keating, Michael J ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

CLL; Prognosis; Richter transformation; Second cancers; Trisomy 12

Indexed keywords

ALEMTUZUMAB; CYCLOPHOSPHAMIDE; FLUDARABINE; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; HEMOGLOBIN; IBRUTINIB; IDELALISIB; LENALIDOMIDE; MEPREDNISONE; MITOXANTRONE; RITUXIMAB; CD38 ANTIGEN; CD38 PROTEIN, HUMAN; MEMBRANE PROTEIN;

ACUTE MYELOBLASTIC LEUKEMIA; AGED; ANEUPLOIDY; ARTICLE; BLADDER CARCINOMA; CANCER COMBINATION CHEMOTHERAPY; CANCER MORTALITY; CAUSE OF DEATH; CHROMOSOME DELETION; CHROMOSOME DELETION 14Q; CHRONIC LYMPHATIC LEUKEMIA; COLON CARCINOMA; COMPARATIVE STUDY; CYTOGENETICS; DISEASE SURVEILLANCE; DRUG MEGADOSE; FAILURE FREE SURVIVAL; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; HEPATOMEGALY; HUMAN; INCIDENCE; LUNG CARCINOMA; LYMPHADENOPATHY; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MALIGNANT TRANSFORMATION; MULTIPLE MYELOMA; MYELODYSPLASTIC SYNDROME; MYELOPROLIFERATIVE NEOPLASM; OVERALL SURVIVAL; PROSTATE CARCINOMA; RICHTER TRANSFORMATION; SECOND CANCER; SOMATIC MUTATION; SPLENOMEGALY; SQUAMOUS CELL CARCINOMA; STOMACH CARCINOMA; THROMBOCYTOPENIA; TREATMENT RESPONSE; TRISOMY 12; UTERUS CARCINOMA; CHROMOSOME 12; DIFFUSE LARGE B CELL LYMPHOMA; GENETICS; METABOLISM; MORTALITY; PATHOLOGY; PATHOPHYSIOLOGY; RETROSPECTIVE STUDY; TRISOMY; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ANTIGENS, CD38; CAUSE OF DEATH; CHROMOSOMES, HUMAN, PAIR 12; FEMALE; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL; LYMPHOMA, LARGE B-CELL, DIFFUSE; MALE; MEMBRANE GLYCOPROTEINS; NEOPLASMS, SECOND PRIMARY; RETROSPECTIVE STUDIES; THROMBOCYTOPENIA; TRISOMY;

EID: 84937516435     PISSN: 21522650     EISSN: 21522669     Source Type: Journal    
DOI: 10.1016/j.clml.2015.02.001     Document Type: Article

References (45)

1. C. Haferlach, F. Dicker, S. Schnittger, and et al. Comprehensive genetic characterization of CLL: a study on 506 cases analysed with chromosome banding analysis, interphase FISH, IgV(H) status and immunophenotyping Leukemia 21 2007 2442 2451
2. H. Dohner, S. Stilgenbauer, A. Benner, and et al. Genomic aberrations and survival in chronic lymphocytic leukemia N Engl J Med 343 2000 1910 1916
3. L. Cro, A. Ferrario, M. Lionetti, and et al. The clinical and biological features of a series of immunophenotypic variant of B-CLL Eur J Haematol 85 2010 120 129
4. E. Matutes, D. Oscier, J. Garcia-Marco, and et al. Trisomy 12 defines a group of CLL with atypical morphology: correlation between cytogenetic, clinical and laboratory features in 544 patients Br J Haematol 92 1996 382 388
5. E. Schlette, L.J. Medeiros, M. Keating, and et al. CD79b expression in chronic lymphocytic leukemia. Association with trisomy 12 and atypical immunophenotype Arch Pathol Lab Med 127 2003 561 566
6. S. Quijano, A. Lopez, A. Rasillo, and et al. Impact of trisomy 12, del(13q), del(17p), and del(11q) on the immunophenotype, DNA ploidy status, and proliferative rate of leukemic B-cells in chronic lymphocytic leukemia Cytometry B Clin Cytom 74 2008 139 149
7. I. Del Giudice, D. Rossi, S. Chiaretti, and et al. NOTCH1 mutations in +12 chronic lymphocytic leukemia (CLL) confer an unfavorable prognosis, induce a distinctive transcriptional profiling and refine the intermediate prognosis of +12 CLL Haematologica 97 2012 437 441
8. Y.O. Huh, C.D. Schweighofer, R.P. Ketterling, and et al. Chronic lymphocytic leukemia with t(14; 19)(q32; q13) is characterized by atypical morphologic and immunophenotypic features and distinctive genetic features Am J Clin Pathol 135 2011 686 696
9. L. Sellmann, S. Gesk, C. Walter, and et al. Trisomy 19 is associated with trisomy 12 and mutated IGHV genes in B-chronic lymphocytic leukaemia Br J Haematol 138 2007 217 220
10. A. Daudignon, S. Poulain, P. Morel, and et al. Increased trisomy 12 frequency and a biased IgVH 3-21 gene usage characterize small lymphocytic lymphoma Leuk Res 34 2010 580 584
11. A.M. Tsimberidou, M.J. Keating, and W.G. Wierda Richter's transformation in chronic lymphocytic leukemia Curr Hematol Malig Rep 2 2007 265 271
12. D. Rossi, M. Cerri, D. Capello, and et al. Biological and clinical risk factors of chronic lymphocytic leukaemia transformation to Richter syndrome Br J Haematol 142 2008 202 215
13. E. Chigrinova, A. Rinaldi, I. Kwee, and et al. Two main genetic pathways lead to the transformation of chronic lymphocytic leukemia to Richter syndrome Blood 122 2013 2673 2682
14. E. Falisi, E. Novella, C. Visco, and et al. B-cell receptor configuration and mutational analysis of patients with chronic lymphocytic leukaemia and trisomy 12 reveal recurrent molecular abnormalities Hematol Oncol 32 2014 22 30
15. V. Balatti, A. Bottoni, A. Palamarchuk, and et al. NOTCH1 mutations in CLL associated with trisomy 12 Blood 119 2012 329 331
16. X.S. Puente, M. Pinyol, V. Quesada, and et al. Whole-genome sequencing identifies recurrent mutations in chronic lymphocytic leukaemia Nature 475 2011 101 105
17. C. Lopez, J. Delgado, D. Costa, and et al. Different distribution of NOTCH1 mutations in chronic lymphocytic leukemia with isolated trisomy 12 or associated with other chromosomal alterations Genes Chromosomes Cancer 51 2012 881 889
18. S.M. Escudier, J.M. Pereira-Leahy, J.W. Drach, and et al. Fluorescent in situ hybridization and cytogenetic studies of trisomy 12 in chronic lymphocytic leukemia Blood 81 1993 2702 2707
19. A. Athanasiadou, K. Stamatopoulos, A. Tsompanakou, and et al. Clinical, immunophenotypic, and molecular profiling of trisomy 12 in chronic lymphocytic leukemia and comparison with other karyotypic subgroups defined by cytogenetic analysis Cancer Genet Cytogenet 168 2006 109 119
20. T.H. Que, J.G. Marco, J. Ellis, and et al. Trisomy 12 in chronic lymphocytic leukemia detected by fluorescence in situ hybridization: analysis by stage, immunophenotype, and morphology Blood 82 1993 571 575
21. M.D. Tabernero, J.F. San Miguel, J.L. Garcia, and et al. Clinical, biological, and immunophenotypical characteristics of B-cell chronic lymphocytic leukemia with trisomy 12 by fluorescence in situ hybridization Cytometry 22 1995 217 222
22. M. Hallek, B.D. Cheson, D. Catovsky, and et al. Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute - Working Group 1996 guidelines Blood 111 2008 5446 5456
23. B.D. Cheson, J.M. Bennett, M. Grever, and et al. National Cancer Institute-Sponsored Working Group guidelines for chronic lymphocytic leukemia: revised guidelines for diagnosis and treatment Blood 87 1996 4990 4997
24. T.D. Shanafelt, T.E. Witzig, S.R. Fink, and et al. Prospective evaluation of clonal evolution during long-term follow-up of patients with untreated early-stage chronic lymphocytic leukemia J Clin Oncol 24 2006 4634 4641
25. L.Z. Rassenti, L. Huynh, T.L. Toy, and et al. ZAP-70 compared with immunoglobulin heavy-chain gene mutation status as a predictor of disease progression in chronic lymphocytic leukemia N Engl J Med 351 2004 893 901
26. N. Muthusamy, H. Breidenbach, L. Andritsos, and et al. Enhanced detection of chromosomal abnormalities in chronic lymphocytic leukemia by conventional cytogenetics using CpG oligonucleotide in combination with pokeweed mitogen and phorbol myristate acetate Cancer Genet 204 2011 77 83
27. A. Criel, I. Wlodarska, P. Meeus, and et al. Trisomy 12 is uncommon in typical chronic lymphocytic leukaemias Br J Haematol 87 1994 523 528
28. A. Criel, G. Verhoef, R. Vlietinck, and et al. Further characterization of morphologically defined typical and atypical CLL: a clinical, immunophenotypic, cytogenetic and prognostic study on 390 cases Br J Haematol 97 1997 383 391
29. G. D'Arena, P. Musto, N. Cascavilla, and et al. CD38 expression correlates with adverse biological features and predicts poor clinical outcome in B-cell chronic lymphocytic leukemia Leuk Lymphoma 42 2001 109 114
30. J.C. Riches, C.J. O'Donovan, S.J. Kingdon, and et al. Trisomy 12 chronic lymphocytic leukemia cells exhibit upregulation of integrin signaling that is modulated by NOTCH1 mutations Blood 123 2014 4101 4110
31. G. Brachtl, J. Pinon Hofbauer, R. Greil, and et al. The pathogenic relevance of the prognostic markers CD38 and CD49d in chronic lymphocytic leukemia Ann Hematol 93 2014 361 374
32. C. Moreau, Q. Liu, R. Graeff, and et al. CD38 structure-based inhibitor design using the 1-cyclic inosine 5′-diphosphate ribose template PLoS One 8 2013 e66247
33. C.S. Zent, W. Ding, S.M. Schwager, and et al. The prognostic significance of cytopenia in chronic lymphocytic leukaemia/small lymphocytic lymphoma Br J Haematol 141 2008 615 621
34. P. Strati, and F. Caligaris-Cappio A matter of debate in chronic lymphocytic leukemia: is the occurrence of autoimmune disorders an indicator of chronic lymphocytic leukemia therapy? Curr Opin Oncol 23 2011 455 460
35. G.F. Bass, E.T. Tuscano, and J.M. Tuscano Diagnosis and classification of autoimmune hemolytic anemia Autoimmun Rev 13 2014 560 564
36. E. Lo, and S. Deane Diagnosis and classification of immune-mediated thrombocytopenia Autoimmun Rev 13 2014 577 583
37. L. Ripolles, M. Ortega, F. Ortuno, and et al. Genetic abnormalities and clinical outcome in chronic lymphocytic leukemia Cancer Genet Cytogenet 171 2006 57 64
38. A. Cosson, E. Chapiro, N. Belhouachi, and et al. 14q deletions are associated with trisomy 12, NOTCH1 mutations and unmutated IGHV genes in chronic lymphocytic leukemia and small lymphocytic lymphoma Genes Chromosomes Cancer 53 2014 657 666
39. S. Bottcher, M. Ritgen, K. Fischer, and et al. Minimal residual disease quantification is an independent predictor of progression-free and overall survival in chronic lymphocytic leukemia: a multivariate analysis from the randomized GCLLSG CLL8 trial J Clin Oncol 30 2012 980 988
40. P. Strati, M.J. Keating, S.M. O'Brien, and et al. Eradication of bone marrow minimal residual disease with first-line chemoimmunotherapy may prompt early treatment discontinuation in chronic lymphocytic leukemia Blood 123 2014 3727 3732
41. M. Giertlova, M. Hajikova, J. Vaskova, and et al. Cytogenetic abnormalities predict treatment-free interval and response to therapy in previously untreated chronic lymphocytic leukemia patients Neoplasma 58 2011 82 88
42. S.A. Parikh, K.G. Rabe, T.G. Call, and et al. Diffuse large B-cell lymphoma (Richter syndrome) in patients with chronic lymphocytic leukaemia (CLL): a cohort study of newly diagnosed patients Br J Haematol 162 2013 774 782
43. A.M. Tsimberidou, S. Wen, P. McLaughlin, and et al. Other malignancies in chronic lymphocytic leukemia/small lymphocytic lymphoma J Clin Oncol 27 2009 904 910
44. B.M. Solomon, K.G. Rabe, S.L. Slager, and et al. Overall and cancer-specific survival of patients with breast, colon, kidney, and lung cancers with and without chronic lymphocytic leukemia: a SEER population-based study J Clin Oncol 31 2013 930 937
45. C.S. Tam, J. Otero-Palacios, L.V. Abruzzo, and et al. Chronic lymphocytic leukaemia CD20 expression is dependent on the genetic subtype: a study of quantitative flow cytometry and fluorescent in-situ hybridization in 510 patients Br J Haematol 141 2008 36 40